IBX 3.13% 3.3¢ imagion biosystems limited

Interesting, page-2418

  1. 2,756 Posts.
    lightbulb Created with Sketch. 779
    M E D I C A L I M A G I N G B R E A K T H R O U G H
    MagSense™ Technology will transform cancer diagnosis



    • Non-invasive – a safe and non-surgical solution to detect cancer

    • No radioactivity - uses bio-safe magnetic nanoparticles to “tag”
    cancer cells


    • Platform technology – can be used for many cancers as well as other
    diseases, e.g. infection and cardiovascular

    • Proprietary - patent issued in most major global markets

    • Breakthrough - technical feasibility and safety profile vetted,
    designated as a “breakthrough device” by FDA


    First indication – metastatic breast cancer, provides shortest path to
    commercialization

    First-in-human – ready for clinical studies - a catalyst for valuation
    and partnering

    .............................................................................................................................................................

    Has all the hallmarks of a "Device" to me.


    C:/Users/x/Desktop/switzer-preso.pdf

    file:///C:/Users/x/Desktop/switzer-preso.pdf
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.